Fumaric Acid

Fumaric Acid

SCHEMBL6300249

Cc1c(F)cc(N2C[C@H](C)NC[C@H]2C)c2occc12.O=C(O)/C=C/C(=O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2C known ✓ P28335 1/20 0.35
MCHR1 Q99705 1/20 0.33
HTR6 P50406 1/20 0.32
ATR Q13535 1/20 0.31
ATRIP Q8WXE1 1/20 0.31
HDAC1 Q13547 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6300251 1.00 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6304767 0.89 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6305349 0.89 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6304771 0.89 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6305351 0.89 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6297988 0.85 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6297986 0.85 HTR2C (0.35) HTR2CMCHR1HTR6ATRATRIP
Fumaric Acid SCHEMBL6305695 0.84 MCHR1 (0.33) HTR2CMCHR1ATRATRIPHDAC1
Fumaric Acid SCHEMBL6299618 0.84 MCHR1 (0.33) HTR2CMCHR1ATRATRIPHDAC1
Fumaric Acid SCHEMBL6299615 0.84 MCHR1 (0.33) HTR2CMCHR1ATRATRIPHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 US disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 EP disclosed